ClinicalTrials.Veeva

Menu

Study About Contrast Media

U

University of Tartu

Status

Enrolling

Conditions

Small Bowel Obstruction

Treatments

Other: Effect on contrast media depending on the time of its administratsion

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

Full description

Patients presenting with symptoms of small bowel obstruction (SBO) will be evaluated and if the diagnosis of adhesive small bowel obstruction is made it must be decided what is the treatment of choice.

If immediate surgery is needed- it will not be delayed If patients are eligible for conservative management- they will be randomized to 2 study groups- contrast media (CM) after 4 hours of nasogastric-tube decompression and after 24 hours of nasogastric-tube decompression.

Contrast media challenge acquires radiographs (X-rays) to be taken after an interval (common practice) decided by the surgeon.

If at any point patient needs surgery- it will not be delayed. The results are compared. The hypothesis is, that if CM is administered sooner- it will help SBO resolution

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 18 years or older
  • Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation
  • No peritonitis present, no need for an emergent surgery
  • Patients sign an informed consent

Exclusion criteria

  • Patients younger than 18 yeas
  • Patients with mechanical small bowel obstruction caused by incarcerated hernias
  • Patients with mechanical small bowel obstruction caused by carcinomatosis
  • Patients with paralytic small bowel obstruction
  • Patients who have undergone surgery within 6 weeks
  • Patients who do not want to be enrolled in the study

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

Contrast media 4 hours
Active Comparator group
Description:
Patients will receive contrast media after 4 hours of nasogastric decompression
Treatment:
Other: Effect on contrast media depending on the time of its administratsion
Contrast media 24 hours
Active Comparator group
Description:
Patients will receive contrast media after 24 hours of nasogastric decompression
Treatment:
Other: Effect on contrast media depending on the time of its administratsion

Trial contacts and locations

1

Loading...

Central trial contact

Ceith Nikkolo, PhD; Liis Jaanimäe, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems